|
|
|
Volumn 16, Issue 8 Suppl 7, 2002, Pages 13-15
|
|
Targeting vascular endothelial growth factor in colorectal cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CAMPTOTHECIN;
DRUG DERIVATIVE;
ENDOTHELIAL CELL GROWTH FACTOR;
FLUOROURACIL;
FOLINIC ACID;
INDOLE DERIVATIVE;
IRINOTECAN;
MONOCLONAL ANTIBODY;
PYRROLE DERIVATIVE;
SEMAXANIB;
TUMOR MARKER;
CLINICAL TRIAL;
COLORECTAL TUMOR;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
MALE;
MORTALITY;
NEOVASCULARIZATION (PATHOLOGY);
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SURVIVAL;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
COLORECTAL NEOPLASMS;
DISEASE-FREE SURVIVAL;
ENDOTHELIAL GROWTH FACTORS;
FEMALE;
FLUOROURACIL;
HUMANS;
INDOLES;
LEUCOVORIN;
MALE;
NEOVASCULARIZATION, PATHOLOGIC;
PROGNOSIS;
PYRROLES;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0036677084
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (20)
|
|
References (22)
|
